GENEVA, April 15 -- OSANNI BIO, INC. (345 California St, Suite 600San Francisco, California 94104) filed a patent application (PCT/US2025/049290) for "COMPOSITIONS AND METHODS FOR MODULATION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE (HMGCR) EXPRESSION" on Oct 02, 2025. With publication no. WO/2026/076276, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HUBER, Hans (c/o Osanni Bio, Inc.345 California St, Suite 600San Francisco, California 94104), ACKERMANN, Douglas Michael (c/o Osanni Bio, Inc.345 California St, Suite 60...